<html><head><title>EC 3.4.15.1</title></head><base href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/4/15/1.html"><body><center><b>IUBMB Enzyme Nomenclature</b><p><h1><b>EC 3.4.15.1</b></h1></center><b>Accepted name:</b> peptidyl-dipeptidase A<p><b>Reaction:</b> Release of a C-terminal dipeptide, oligopeptide&#9532;Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of angiotensin I to angiotensin II, with increase in vasoconstrictor activity, but no action on angiotensin II<p><b>Glossary:</b> captopril = (2<i>S</i>)-1-(3-mercapto-2-methylpropanoyl)-<small>L</small>-proline<p><b>Other name(s):</b> dipeptidyl carboxypeptidase I; peptidase P; dipeptide hydrolase (ambiguous); peptidyl dipeptidase; angiotensin converting enzyme; kininase II; angiotensin I-converting enzyme; carboxycathepsin; dipeptidyl carboxypeptidase; peptidyl dipeptidase I; peptidyl-dipeptide hydrolase; peptidyldipeptide hydrolase; endothelial cell peptidyl dipeptidase; ACE; peptidyl dipeptidase-4; PDH; peptidyl dipeptide hydrolase; DCP<p><b>Comments:</b> A Cl<small><sup>&#150;</sup></small>-dependent, zinc glycoprotein that is generally membrane-bound. A potent inhibitor is captopril. Important in elevation of blood pressure, through formation of angiotensin II (vasoconstrictor) and destruction of bradykinin (vasodilator). Two molecular forms exist in mammalian tissues, a widely-distributed somatic form of 150- to 180-kDa that contains two non-identical catalytic sites, and a testicular form of 90- to 100-kDa that contains only a single catalytic site. Type example of peptidase family M2<p><b>Links to other databases:</b> <a href="http://www.brenda-enzymes.org/enzyme.php?ecno=3.4.15.1" target="new">BRENDA</a>, <a href="http://enzyme.expasy.org/EC/3.4.15.1" target="new">EXPASY</a>, <a href="http://www.genome.ad.jp/dbget-bin/www_bget?ec:3.4.15.1" target="new">KEGG</a>, <a href="http://merops.sanger.ac.uk/cgi-bin/merops.cgi?id=m02.001" target="new">MEROPS</a>, <a href="http://www.metacyc.org/META/NEW-IMAGE?type=EC-NUMBER&object=EC-3.4.15.1" target="new">Metacyc</a>,<a href="http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/enzymes/GetPage.pl?ec_number=3.4.15.1" target="new">PDB</a>, CAS registry number: 9015-82-1<p><b>References:</b><p>1. Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G. and Corvol, P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. <i>Proc. Natl. Acad. Sci. USA</i> 85 (1988) 9386-9390. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/2849100?dopt=Abstract" target="new">2849100</a>]<p>2. Ehlers, M.R.W., Fox, E.A., Strydom, D.J. and Riordan, J.F. Molecular cloning of human testicular angiotensin-converting enzyme: the testis enzyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. <i>Proc. Natl. Acad. Sci. USA</i> 86 (1989) 7741-7745. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/2554286?dopt=Abstract" target="new">2554286</a>]<p>3. Wei, L., Clauser, E., Alhenc-Gelas, F. and Corvol, P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. <i>J. Biol. Chem.</i> 267 (1992) 13398-13405. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/1320019?dopt=Abstract" target="new">1320019</a>]<p>4. Corvol, P., Williams, T.A. and Soubrier, F. Peptidyl dipeptidase A: angiotensin I-converting enzyme. <i>Methods Enzymol.</i> 248 (1995) 283-305. [PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7674927?dopt=Abstract" target="new">7674927</a>]<p><center><small>[EC 3.4.15.1 created 1972, modified 1981, modified 1989, modified 1996, modified 2011]</small></center><p><hr>Return to <a href="../15/">EC 3.4.15 home page</a><br>Return to <a href="../">EC 3.4 home page</a><br>Return to <a href="../../">EC 3 home page</a><br>Return to <a href="../../../">Enzymes home page</a><br>Return to <a href="../../../../">IUBMB Biochemical Nomenclature home page</a><p></body></html>